Filing Details

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. 1) 

 

HOTH THERAPEUTICS, INC. 

(Name of Issuer)

 

COMMON STOCK 

(Title of Class of Securities)

 

44148G 10 5 

(CUSIP Number)

 

December 31, 2020 

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☒

Rule 13d-1(b)

 

☐

Rule 13d-1(c)

 

☐

Rule 13d-1(d)

 

 

 

CUSIP No. 44148G 10 5

  

1	NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)   Matthew Eitner
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*	(a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER    18,750(1)
	6	SHARED VOTING POWER   0
	7	SOLE DISPOSITIVE POWER   18,750(1)
	8	SHARED DISPOSITIVE POWER   0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   18,750(1)
10	CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9   0.14% (based on 13,439,229 shares outstanding as of January 7, 2021)
12	TYPE OF REPORTING PERSON   IN

 

(1)

Represents (i) 15,000 shares of common stock held by Mr. Eitner and (ii) 3,750 shares of common stock underlying warrants to purchase common stock held by Mr. Eitner.

 

  

Item 1(a).

Name of Issuer:

 

Hoth Therapeutics, Inc., a Nevada corporation (“Issuer”).

 

Item 1(b).

Address of Issuer's Principal Executive Offices:

 

1 Rockefeller Plaza, Suite 1039, New York, NY 10020.

 

Item 2(a).

Name of Person Filing.

 

The statement is filed on behalf of Matthew Eitner (the “Reporting Person”).

 

Item 2(b).

Address of Principal Business Office or, if None, Residence.

 

521 Fifth Avenue, 12^th Floor, New York, NY 10175

 

Item 2(c).

Citizenship.

 

The Reporting Person is a citizen of the United States.

 

Item 2(d).

Title of Class of Securities.

 

Common Stock, par value $0.0001.

 

Item 2(e).

CUSIP Number.

 

44148G 10 5

 

Item 3.

If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is a

 

(a) ☒ Broker or dealer registered under section 15 of the Act.

 

Item 4.

Ownership.

 

(a) Amount beneficially owned: 18,750(1)

 

(b) Percent of class 0.14% (based on 13, 439,229 shares common stock outstanding as of January 7, 2021)

 

(c) Number of shares as to which the person has:

 

(i) Sole power to vote or to direct the vote: 18,750(1)

(ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or to direct the disposition of: 18,750(1)

(iv) Shared power to dispose or to direct the disposition of: 0

 

(1)

Represents (i) 15,000 shares of common stock held by Mr. Eitner and  (ii) 3,750 shares of common stock underlying warrants to purchase common stock held by Mr. Eitner.

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check following ☒.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.

 

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9.

Notice of Dissolution of Group.

 

Not applicable.

 

Item 10.

Certifications.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

  

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

	Matthew Eitner
Date: February 16, 2021	/s/ Matthew Eitner
	Matthew Eitner

 

 

5